Secretome analysis of clostridium difficile strains

Archives of Microbiology

Volumn 194, Issue 8, 2012, Pages 675-687

  Boetzkes, Alexander ^a   Felkel, Katharina Wiebke ^a   Zeiser, Johannes ^a   Jochim, Nelli ^a   Just, Ingo ^a   Pich, Andreas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Clostridium difficile; Hypervirulent strains; MS analysis; Secretome

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE BINDING COMPONENT PROTEIN; BACTERIAL PROTEIN; HYDROLASE; MICROORGANISM PROTEIN; PILIN; PROTEOME; TOXIN A; TOXIN B; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; ION TRAP MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; RIBOTYPING; SIGNAL TRANSDUCTION; SPECIES COMPARISON; SUPERNATANT;

ADP RIBOSE TRANSFERASES; BACTERIAL PROTEINS; BACTERIAL TOXINS; CHROMATOGRAPHY, LIQUID; CLOSTRIDIUM DIFFICILE; MASS SPECTROMETRY; PROTEOME; SPECIES SPECIFICITY;

CLOSTRIDIUM DIFFICILE;

EID: 84865991398     PISSN: 03028933     EISSN: 1432072X     Source Type: Journal    
DOI: 10.1007/s00203-012-0802-5     Document Type: Article

References (36)

1. Akerlund T, Persson I, Unemo M, Norén T, Svenungsson B, Wullt M, Burman LG (2008) Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol 46: 1530-1533
2. Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340: 783-795
3. Bendtsen JD, Kiemer L, Fausbøll A, Brunak S (2005) Non-classical protein secretion in bacteria. BMC Microbiol 5:58-64
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248
5. Cartman ST, Heap JT, Kuehne SA, Cockayne A, Minton NP (2010) The emergence of 'hypervirulence' in Clostridium difficile. Int J Med Microbiol 300:387-395
6. Frei R, Nagy E, Bouza E, Marin M, Akerlund T, Virolainen-Julkunen A, Lyytikäinen O, Kotila S, Ingebretsen A, Smyth B et al (2008) Update of Clostridium difficile infection due to PCR ribotype 027 in Europe. Euro Surveill 13:18942-18951
7. Gerhard R, Burger S, Tatge H, Genth H, Just I, Hofmann F (2005) Comparison of wild type with recombinant Clostridium difficile toxin. Microb Pathog 38:77-83
8. Gerhard R, Nottrott S, Schoentaube J, Tatge H, Olling A, Just I (2008) Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. J Med Microbiol 57:765-770
9. Hall A (2005) Rho GTPases and the control of cell behaviour. Biochem Soc Trans 33:891-895
10. Hammond GA, Johnson JL (1995) The toxigenic element of Clostridium difficile strain VPI10463. Microb Pathog 19: 203-213
11. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, Holt KE, Seth-Smith HM, Quail MA, Rance R et al (2010) Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci USA 107:7527-7532
12. Jain S, Graham RLJ, McMullan G, Ternan NG (2010) Proteomic analysis of the insoluble subproteome of Clostridium difficile strain 630. FEMS Microbiol Lett 312:151-159
13. Jain S, Graham C, Graham RLJ, McMullan G, Ternan NG (2011) Quantitative proteomics analysis of the heat stress response in Clostridium difficile strain 630. J Proteom Res 10:3880-3890
14. Jeffrey CJ (2005) Mass spectrometry and the search for moonlighting proteins. Mass Spec Rev 24:772-782
15. Just I, Gerhard R (2004) Large clostridial cytotoxins. Rev Physiol Biochem Pharmacol 152:23-47
16. Karlsson S, Burman LG, Akerlund T (1999) Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology 145:1683-1693
17. Kelly CP, LaMont JT (2008) Clostridium difficile-more difficult than ever. N Engl J Med 359:1932-1940
18. King RN, Lager SL (2011) Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid suppression therapy. Pharmacotherapy 31:642-648
19. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP (2010) The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711-713
20. Kuijper EJ, van Dissel JT, Wilcox MH (2007) Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis 20:376-383
21. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
22. Lawley TD, Croucher NJ, Yu L, Clare S, Sebaihia M, Goulding D, Pickard DJ, Parkhill J, Choudhary J, Dougan G (2009) Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores. J Bacteriol 191:5377-5386
23. Luecke N, Neumann D, Templin C, Muetzelburg MV, Just I, Picha R (2010) Secretom Analysis Of The Hematopoietic Progenitor Cell Line DKmix Using LC-MALDI Techniques. Rapid Commun Mass Spectrom 24:561-570
24. Macy JM, Snellen JE, Hungate RE (1972) Use of syringe methods for anaerobiosis. Am J Clin Nutr 25:1318-1323
25. Mukherjee K, Karlsson S, Burman LG, Akerlund T (2002) Proteins released during high toxin production in Clostridium difficile. Microbiology 148:2245-2253
26. Murray R, Boyd D, Levett PN, Mulvey MR, Alfa MJ (2009) Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect Dis 9:103-107
27. Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR (1997) Production of a complete binary toxin (actin-specific ADPribosyltransferase) by Clostridium difficile. Infect Immun 65:1402-1407
28. Schwan C, Stecher B, Tzivelekidis T, van Ham M, Rohde M, Hardt WD, Wehland J, Aktories K (2009) Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog 5(10):e1000626
29. Smith BE, Hill JA, Gjukich MA, Andrews PC (2011) Tranche distributed repository and proteomecommons.org. Meth Mol Biol 696:123-145
30. Stabler RA, He M, Dawson L, Martin M, Valiente E, Corton C, Sebaihia M, Quail MA, Rose G, Gerding DN et al (2009) Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10:102-108
31. Viswanathan V, Mallozzi M, Vedantam G (2010) Clostridium difficile infections: an overview of the disease and its pathogenesis, epidemiology and interventions. Gut Microbes 1:234-242
32. Warny M, Pepin J, Fang A, Killigore G, Thompson A, Brazier J, Frost E, McDonnald IC (2005) Toxin production by emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084
33. Wenger CD, Phanstiel DH, Lee MV, Bailey DJ, Coon JJ (2011) Compass: a suite of pre- and post-search proteomics software tools for OMSSA. Proteomics 11:1064-1074
34. Wessel D, Flügge UI (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 138:141-143
35. Wright A, Wait R, Begum S, Crossett B, Nagy J, Brown K (2005) Proteomic analysis of cell surface proteins from Clostridium difficile. Proteomics 5:2443-2452
36. Yamakawa K, Karasawa T, Ikoma S, Nakamura S (1996) Enhancement of Clostridium difficile toxin production in biotin-limited conditions. J Med Microbiol 44:111-114